Epidemiology of prostate cancer: Molecular and environmental clues

Urology

Volumn 48, Issue 5, 1996, Pages 676-683

  Pienta, Kenneth J ^a   Goodson, Jo Ann ^a   Esper, Peggy S ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BETA CAROTENE; CAROTENE; DNA; ESTROGEN; FAT; LYCOPENE; PROLACTIN; RETINOL; STEROID HORMONE; TESTOSTERONE; XANTHOPHYLL;

AGE; CANCER INCIDENCE; DNA METHYLATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FAT INTAKE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HORMONE BLOOD LEVEL; HUMAN; LIFESTYLE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REVIEW; TUMOR SUPPRESSOR GENE; UNITED STATES; VASECTOMY;

AGE FACTORS; CONTINENTAL POPULATION GROUPS; DIET; ENVIRONMENTAL HEALTH; HUMANS; MALE; MASS SCREENING; PROSTATIC NEOPLASMS; TESTOSTERONE; VASECTOMY;

EID: 0030298483     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00219-1     Document Type: Review

References (76)

1. 1. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics, 1996. CA 46: 5-27, 1996.
2. 2. Pienta KJ, and Esper PE: Risk factors for prostate cancer. Ann Intern Med 118: 793-803, 1993.
3. 3. Wingo PA, Bolden S, Tong T, Parker SL, Martin LM, and Heath CW Jr: Cancer statistics for African Americans, 1996. CA 46: 113-126, 1996.
4. 4. Yu H, Harris RE, Gao Y, Gao R, and Wynder EL: Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20: 76-81, 1991.
5. 5. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, and Mack TM: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63: 963-966, 1991.
6. 6. Carter HB, Piantadosi S, and Isaacs JT: Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143: 742-726, 1990.
7. 7. Carter HB, and Coffey DS: The prostate: an increasing medical problem. Prostate 16: 39-48, 1990.
8. 8. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, and Ewing CM: Molecular genetics and chromosomal alterations in prostate cancer. Cancer 75: 2004-2012, 1995.
9. 9. Pienta KJ: The epidemiology, etiology, and prevention of carcinoma of the prostate, in Walsh PC, Vaughn ED Jr, Retik AB, and Wein AJ (Eds): Campbell's Textbook of Urology. Philadelphia, WB Saunders, 1996 (in press).
10. 10. Carter BS, Beaty TH, Steinberg GD, Childs B, and Walsh PC: Mendelian inheritance of familial prostate cancer. Proc Nad Acad Sci USA 89: 3367-3371, 1992.
11. 11. Irvine RA, Yu MC, Ross RK, and Coetzee GA: The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55: 1937-1940, 1995.
12. 12. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, and Nelson WG: Cytidine methylation of regulatory sequences near the pi class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733-11737, 1994.
13. 13. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosomal instability in human prostate cancer. Cancer Res 54: 3824-3830, 1994.
14. 14. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, and Schalken JA: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933, 1994.
15. 15. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, and Inuzuka M: Presence of ras oncogene mutations and human papilloma virus DNA in human prostate carcinoma. Cancer Res 52: 5991-5996, 1992.
16. 16. Bookstein R, Rio P, Madreperla S, Hong F, Allred C, Grizzle W, and Lee WH: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762-7767, 1990.
17. 17. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
18. 18. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, and Conti CJ: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85: 1657-1669, 1993.
19. 19. Taplin ME, Bubley GJ, Sinister TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, and Balk SP: Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398, 1995.
20. 20. Bostwick DG, and Brawer MK: Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788-794, 1987.
21. 21. Brawer MK: Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 23: 242-248, 1992.
22. 22. De La Torre M, Haggman M, Brandstedt S, and Busch C: Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy. Br J Urol 72: 207-213, 1993.
23. 23. Quinn BD, Cho KR, and Epstein JI: Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 65: 2328-2337, 1990.
24. 24. Sakr WA, Haas GP, Cassin BF, Pontes JE, and Crissman JD: The frequency of carcinoma and prostatic intraepithelial neoplasia of the prostate in young males. J Urol 150: 379-385, 1993.
25. 25. Keetch DW, Humphrey P, Stahl D, Smith DS, and Catalona WJ: Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 154: 347-351, 1995.
26. 26. Weinberg DS, and Weidner N: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Arch Pathol Lab Med 117: 1132-1137, 1993.
27. 27. Barreton GB, Vogt T, Blasenbreu S, and Lohrs U: Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol 25: 506-513, 1994.
28. 28. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, and Linehan WM: Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55: 2959-2962, 1995.
29. 29. Demers RY, Swanson GM, Weiss LK, and Kau TY: Increasing incidence of cancer of the prostate. Arch Intern Med 154: 1211-1216, 1994.
30. 30. Morton RA Jr: Racial differences in adenocarcinoma of the prostate in North American men. Urology 44: 637-645, 1994.
31. 31. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, and Severson RK: Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology 45: 93-101, 1995.
32. 32. Mebane C, Gibbs T, and Horm J: Current status of prostate cancer in North American black males. J Natl Med Assoc 82: 782-788, 1990.
33. 33. Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, and Robertson CN: Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 46: 346-351, 1995.
34. 34. Potosky AL, Miller BA, Albertsen PC, and Kramer BS: The role of increasing detection in the rising incidence of prostate cancer. JAMA 273: 548-552, 1995.
35. 35. Taylor JD, Holmes TM, and Swanson GM: Descriptive epidemiology of prostate cancer in metropolitan Detroit. Cancer 73: 1704-1707, 1994.
36. 36. Baquet CR, Horm JW, Gibbs T, and Greenwald P: Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83: 551-557, 1991.
37. 37. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et al: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87: 652-661, 1995.
38. 38. Ross RK, Bernstein L, Judd H, Hanisch R, Pike M, and Henderson B: Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76: 45-48, 1986.
39. 39. Austin JP, Aziz H, Potters L, Thelmo W, Chen P, Choi K, Brandys M, Macchia RJ, and Rotman M: Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 13: 465-469, 1990.
40. 40. Austin JP, and Convery K: Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol 16: 140-145, 1993.
41. 41. Whittemore AS, Keller JB, and Betensky R: Low grade latent prostate cancer volume: predictor of clinical cancer incidence? J Natl Cancer Inst 83: 1231-1235, 1991.
42. 42. Gronberg H, Damber L, and Damber JE: Familial prostate cancer in Sweden. Cancer 77: 138-143, 1996.
43. 43. Woolf CM: An investigation of the familial aspects of carcinoma of the prostate. Cancer 13: 739-744, 1960.
44. 44. Krain LS: Some epidemiologic variables in prostatic carcinoma in California. Prev Med 3: 154-159, 1974.
45. 45. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, and Smart CR: Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1: 47-69, 1982.
46. 46. Meikle W, Smith J, and West D: Familial factors affecting prostatic cancer risk and plasma steroid levels. Prostate 6: 121-128, 1985.
47. 47. Steinberg GD, Carter BS, Beaty TH, Childs B, and Walsh PC: Family history and the risk of prostate cancer. Prostate 17: 337-347, 1990.
48. 48. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, and Newell GR: Familial patterns of prostate cancer: a case control analysis. J Urol 146: 1305-1307, 1991.
49. 49. Ghadirian P, Cadotte M, Lacroix A, and Perret C: Familial aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 19: 43-52, 1991.
50. 50. Goldgar DE, Easton DF, Cannon-Albright LA, and Skolnick MH: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608, 1994.
51. 51. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, and Walsh PC: Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150: 797-802, 1993.
52. 52. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, and Stamey T: Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141: 732-740, 1995.
53. 53. Aprikian AG, Bazinet M, Plante M, Meshref A, Trudel C, Aronson S, Nachabe M, Peloquin F, Dessureault J, Narod S, et al: Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J Urol 154: 404-406, 1995.
54. 54. Carter BS, Beaty TH, Steinberg GD, Childs B, and Walsh PC: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371, 1992.
55. 55. Armstrong B, and Doll R: Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 15: 617-631, 1975.
56. 56. Rose DP, Boyar AP, and Wynder EL: International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58: 2362-2371, 1986.
57. 57. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, and Willet WC: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571-1579, 1993.
58. 58. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, and Stampfer MJ: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86: 281-286, 1994.
59. 59. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, and Hirohata T: Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5: 276-282, 1994.
60. 60. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, and Willet WC: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87: 1767-1776, 1995.
61. 61. West DW, Slattery ML, Robison LM, French TK, and Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2: 84-94, 1991.
62. 62. Mills PK, Beeson WL, Phillips RL, and Eraser GE: Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer 64: 598-604, 1989.
63. 63. Kolonel LN, Hankin JH, and Yoshizawa CN: Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Res 47: 2982-2985, 1987.
64. 64. Montie JE, and Pienta KJ: A review of the role of androgenic hormones in the pathogenesis of benign prostatic hypertrophy and prostate cancer. Urology 43: 892-899, 1994.
65. 65. Hamalainen E, Adlercreutz H, Puska P, and Pietinen P: Diet and serum sex hormones in healthy men. J Steroid Biochem 20: 459-464, 1984.
66. 66. Wynder EL, Laakso K, Sotarauta M, and Rose DP: Metabolic epidemiology of prostatic cancer. Prostate 5: 47-53, 1984.
67. 67. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike M, and Henderson B: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339: 887-889, 1992.
68. 68. Adlercreutz H: Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50(Suppl): 3-23, 1990.
69. 69. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, and Willett WC: A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 269: 873-877, 1993.
70. 70. Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, and Colditz GA: A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 269: 878-882, 1993.
71. 71. Hayes RB, Pottem LM, Greenberg R, Schoenberg J, Swanson GM, Liff J, Schwartz AG, Brown LM, and Hoover RN: Vasectomy and prostate cancer in US blacks and whites. AmJ Epidemiol 137: 263-269, 1993.
72. 72. DerSimonian R, Clemens J, Spirtas R, and Perlman J: Vasectomy and prostate cancer risk: methodological review of the evidence. J Clin Epidemiol 46: 163-172, 1993.
73. 73. Howards SS: Possible biologic mechanisms for a relationship between vasectomy and prostatic cancer. Eur J Cancer 29A: 1060-1062, 1993.
74. 74. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S, and Shapiro S: The relation of vasectomy to the risk of cancer. Am J Epidemiol 140: 431-438, 1994.
75. 75. John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ, et al: Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst 87: 662-669, 1995.
76. 76. Sidney S: Vasectomy and the risk of prostatic cancer and benign prostatic hypertrophy. J Urol 138: 795-797, 1987.